---
$id: https://graph.org.ai/products/commodity/51142023
$type: Product
source: UNSPSC
code: "51142023"
title: "Dixyrazine"
class: "51142000"
classTitle: "Non narcotic analgesics and antipyretics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dixyrazine

**UNSPSC Code**: 51142023
**Class**: [Non narcotic analgesics and antipyretics](Non narcotic analgesics and antipyretics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a non-narcotic analgesic, antiemetic, and antipsychotic agent with the molecular formula C24H33N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7H368W3AYC, chemically known as ethanol, 2-(2-(4-(2-methyl-3-phenothiazin-10-ylpropyl)-1-piperazinyl)ethoxy)- but generally known as dixyrazine, which bears US NIH Compound Identifier 17182. European Medicines Agency schedules Dixyrazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13640MIG. World Health Organization schedules dixyrazine in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, DIXYRAZINE remains the US FDA Preferred Term for this commodity. SMILES: S1C2C(N(CC(CN3CCN(CC3)CCOCCO)C)C3C1CCCC3)CCCC2. .

